Beruflich Dokumente
Kultur Dokumente
L-Proline:
Introduction
764
Among the various nitrogen-containing heterocycles, benzimidazole and its derivatives are common building blocks in biologically
active and therapeutically useful compounds. They exhibit significant pharmacological and biological activities such as anticonvulsant, anticancer, antiulcer, antihypertensive, antibacterial and
antihistaminic properties.[15] In addition, they have been applied
in other fields, such as chemosensing,[6] dyes,[7] fluorescence and
corrosion science.[8] Their synthesis is one of the most exciting
topics in practical organic synthesis. In general, benzimidazoles
have various reported syntheses, with two methods used extensively that employ o-phenylenediamine as starting material. One
is the coupling of carboxylic acids, and the other is the condensation of aldehydes. They both have some drawbacks: the former
requires strong acidic conditions, and sometimes high
temperature[913]; the latter requires a stoichiometric oxidant, involves the generation of environmentally hazardous/toxic byproducts and requires odorous and unstable aldehydes.[1420]
Therefore, developing new efficient and greener methods for the
synthesis of benzimidazoles is an important task.
In recent years, the synthesis of benzimidazoles from
2-iodoaniline as a practical and efficient method has aroused
great interest. These methods often involve the condensation
of 2-iodoaniline and aldehydes/NaN3[21] or benzamidine
hydrochloride.[22] However, these methods have some drawbacks,
such as requiring highly toxic NaN3 and unstable aldehydes, hygroscopic benzamidine hydrochloride and a nitrogen atmosphere.
Very recently, Cano et al.[23] developed an interesting protocol
for the synthesis of benzimidazoles via cascade reaction of
2-iodoaniline and amides. However, the yields were not very
satisfactory and the reaction time was too long. As we know,
amides can be prepared easily from nitriles by hydrolysis. Also,
in 2013, Xiang et al.[24] synthesized N-arylamides from aryl
halides and nitriles. The use of nitriles as nitrogen nucleophiles
can make the synthesis of N-arylamides simpler than that from
Appl. Organometal. Chem. 2014, 28, 764767
Entry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
PhCN (equiv.)
Cu (mol%)
Ligand (mol%)
Base (equiv.)
H2O (equiv.)
Solvent
Temperature (C)
Yield (%)b
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1.2
1.5
0.8
1.2
1.2
1.2
1.2
1.2
1.2
1.2
1.2
1.2
1.2
1.2
CuI (10)
CuI (10)
CuI (10)
CuI (10)
CuI (10)
CuI (10)
Cu2O (10)
CuCl (10)
CuBr (10)
CuBr2 (10)
Cu(OAc)2 (10)
Cu(ClO4)2 (10)
CuCl2 (10)
CuCl2 (10)
CuCl2 (10)
CuCl2 (10)
CuCl2 (10)
CuCl2 (10)
CuCl2 (10)
CuCl2 (10)
CuCl2 (10)
CuCl2 (10)
CuCl2 (10)
CuCl2 (10)
CuCl2 (10)
CuCl2 (10)
CuCl2 (10)
CuCl2 (10)
CuCl2 (5)
CuCl2 (20)
CuCl2 (10)
CuCl2 (10)
CuCl2 (10)
CuCl2 (10)
CuCl2 (10)
CuCl2 (10)
L1 (10)
L1 (10)
L1 (10)
L1 (10)
L1 (10)
L1 (10)
L1 (10)
L1 (10)
L1 (10)
L1 (10)
L1 (10)
L1 (10)
L2 (10)
L3 (10)
L4 (10)
L2 (10)
L2 (10)
L2 (10)
L2 (10)
L2 (10)
L2 (10)
L2 (10)
L2 (10)
L2 (10)
L2 (10)
L2 (10)
L2 (10)
L2 (10)
L2 (10)
L2 (5)
L2 (20)
L2 (10)
L2 (10)
L2 (10)
L2 (10)
20
20
20
20
20
0
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
10
5
30
10
10
10
10
10
10
10
10
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMF
Dioxane
DMP
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
80
60
Room temp.
100
100
100
100
100
100
100
100
100
100
100
100
100
100
68
46
Trace
59
40
64
14
74
76
70
58
18
65
83
85
24
20
54
68
46
75
48
12
87
84
65
90
85
79
82
90
73
90
90
82
78
90
wileyonlinelibrary.com/journal/aoc
765
Reaction conditions: 2-iodoaniline (0.5 mmol), benzonitrile, Cu salt, ligand, base, H2O, solvent (1 ml) were mixed in a 5 ml three-necked flask, and then
stirred rapidly for several hours. The reaction progress was monitored by TLC.
b
Isolated yield.
Entry
Time (h)
Yield (%)b
1a
1b
1c
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
I
Br
Cl
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
4-Cl
4-NO2
H
H
C6H5
C6H5
C6H5
4-BrC6H4
4-ClC6H4
2-ClC6H4
2-, 4-ClC6H3
4-NO2C6H4
4-MeOC6H4
4-Me2NC6H4
4-IsopropylC6H4
3,4,5-MeOC6H2
1-Naphthyl
Styryl
2-Furyl
5-Methyl-2-furyl
Pyridin-2-yl
C6H5
C6H5
n-C7H15
n-C11H23
24
36
36
24
24
24
24
20
24
24
24
24
24
28
30
30
30
26
32
24
24
90
32
Trace
81
83
62
79
94
91
87
85
82
83
42
65
71
68
84
80
Trace
Trace
766
wileyonlinelibrary.com/journal/aoc
Conclusions
We have developed an efficient CuCl2/L-proline-catalyzed method
for the synthesis of benzimidazole and its derivatives from
2-iodoaniline and aromatic nitriles. A wide variety of benzimidazoles could be successfully synthesized in moderate to excellent
yields. On the whole, this approach is an extension of the work of
Xiang et al.[24] and using nitriles as the reaction partners for the
synthesis of benzimidazoles.
Experimental
All starting materials were purchased from commercial sources and
used without further treatment. Melting points were determined
with a Thomas Hoover capillary apparatus and were uncorrected.
All known compounds were identified by appropriate techniques such as 1H NMR and compared with previously reported
data. 1H NMR (500 MHz) spectra were recorded using a Bruker
500 spectrometer with tetramethylsilane as an internal standard.
Mass spectra were recorded using an Agilent Technologies 6110
quadrupole LC/MS equipped with an electrospray ionization
probe operating in positive ion mode. Analytical TLC was
performed on precoated silica gel 60 F254 plates. Yields refer
to the isolated yields of the products after purification by silicagel column chromatography (300 mesh).
Typical Procedure for the Synthesis of Benzimidazoles
References
[1] W. A. Denny, G. W. Rewcastle, B. C. Bauley, J. Med. Chem. 1990, 33, 814.
[2] T. Gngr, A. Fouquet, J.-M. Eulon, D. Provost, M. Cazes, A. Cloarec,
J. Med. Chem. 1992, 35, 4455.
[3] E. Seyhan, N. Sultan, A. Nilgun, N. Noyanalpan, Arzneim.-Forsch. 1997,
47, 410.
[4] L. Hu, M. L. Kully, D. W. Boykin, N. Abood, Bioorg. Med. Chem. Lett. 2009,
19, 3374.
[5] a) R. Schiffmann, A. Neugebauer, C. D. Klein, J. Med. Chem. 2006, 49,
511; b) R. P. Verma, Bioorg. Med. Chem. 2005, 13, 1059; c)
K.-J. Soderlind, B. Gorodetsky, A. K. Singh, N. Bachur, G. G. Miller,
J. W. Loun, Anti-Cancer Drug Des. 1999, 14, 19; d) D. A. Horton,
G. T. Bourne, M. L. Smythe, Chem. Rev. 2003, 103, 893; e) T. Roth,
M. L. Morningstar, P. L. Boyer, S. H. Hughes, R. W. Buckheit Jr.,
C. J. Michejda, J. Med. Chem. 1997, 40, 4199.
[6] N. Singh, D. O. Jang, Org. Lett. 2007, 9, 1991.
[7] J. A. Asensio, P. Gomez-Romero, Fuel Cells 2005, 5, 336.
[8] a) P. Chaudhuri, B. Ganguly, S. Bhattacharya, J. Org. Chem. 2007, 72,
1912; b) A. Sannigrahi, D. Arunbabu, R. M. Sankar, T. Jana,
Macromolecules 2007, 40, 2844; c) Y. Ooyama, T. Nakamura,
K. Yoshida, New J. Chem. 2005, 29, 447.
[9] Y. Wang, K. Sarris, D. R. Sauer, S. W. Djuric, Tetrahedron Lett. 2006, 47, 4823.
[10] a) W. Huang, R. M. Scarborough, Tetrahedron Lett. 1999, 40, 2665; b)
Y.-C. Chi, C.-M. Sun, Synlett 2000, 591; c) D. Kumar, M. R. Jacob,
M. B. Reynolds, S. M. Kerwin, Bioorg. Med. Chem. 2002, 10, 3997; d)
B. Gong, F. Hong, C. Kohm, L. Bonham, P. Klein, Bioorg. Med. Chem.
Lett. 2004, 14, 1455; e) S.-T. Huang, I.-J. Hsei, C. Chen, Bioorg. Med.
Chem. 2006, 14, 6106.
[11] a) D. W. Dunwell, D. Evans, C. E. Smith, W. R. N. Williamson, J. Med. Chem.
1975, 18, 692; b) I. B. Dzvinchuk, A. V. Vypirailenko, M. O. Lozinskii, Russ.
J. Org. Chem. 1998, 34, 685.
[12] a) E. Barni, P. J. Savarino, J. Heterocycl. Chem. 1979, 16, 1583; b)
J. B. Hendrickson, M. S. Hussoin, J. Org. Chem. 1987, 52, 4137; c)
T. Gungor, A. Fouquet, J.-M. Teulon, D. Provost, M. Cazes, A. Cloarec,
J. Med. Chem. 1992, 35, 4455; d) A. W. White, R. Almassy, A. H. Calvert,
N. J. Curtin, R. J. Griffin, Z. Hostomsky, K. Maegley, D. R. Newell,
S. Srinivasan, B. T. Golding, J. Med. Chem. 2000, 43, 4084; e)
B. Biasotti, S. Dallavalle, L. Merlini, C. Farina, S. Gagliardi, C. Parini,
P. Belfiore, Bioorg. Med. Chem. 2003, 11, 2247.
[13] a) K. Bougrin, A. Loupy, M. Soufiaoui, Tetrahedron 1998, 54, 8055; b)
A. Ben-Alloum, S. Bakkas, M. Soufiaoui, Tetrahedron Lett. 1998, 39,
4481; c) G. V. Reddy, V. V. V. N. S. R. Rao, B. Narsaiah, P. S. Rao, Synth.
Commun. 2002, 2467; d) Z. Mao, Z. Wang, J. Li, X. Song, Y. Luo, Synth.
Commun. 2010, 40, 1963.
[14] F. F. Stephens, J. D. Bower, J. Chem. Soc. 1949, 2971.
[15] R. L. Lombardy, F. A. Tanious, K. Ramachandran, R. R. Tidwell,
W. D. Wilson, J. Med. Chem. 1996, 39, 1452.
[16] K. Bahrami, M. M. Khodaei, A. Nejati, Green Chem. 2010, 12, 1237.
[17] a) J. J. Vanden Eynde, F. Delfosse, P. Lor, Y. Van Haverbeke,
Tetrahedron 1995, 51, 5813; b) K. J. Lee, K. D. Janda, Can. J. Chem.
2001, 79, 1556.
[18] I. Bhatnagar, M. V. George, Tetrahedron 1968, 24, 1293.
[19] P. L. Beaulieu, B. Hache, E. von Moos, Synthesis 2003, 1683.
[20] K. Bahrami, M. M. Khodaei, I. Kavianinia, Synthesis 2007, 547.
[21] Y. Kim, M. R. Kumar, N. Park, Y. Heo, S. Lee, J. Org. Chem. 2011, 76, 9577.
[22] Y. Qu, L. Pan, Z. Wu, X. Zhou, Tetrahedron 2013, 69, 1717.
[23] R. Cano, D. J. Ramon, M. Yus, J. Org. Chem. 2011, 76, 654.
[24] S.-K. Xiang, D.-X. Zhang, H. Hu, J.-L. Shi, L.-G. Guo, C. Feng, B.-Q. Wang,
K.-Q. Zhao, P. Hu, H. Yang, W.-H. Yu, Adv. Synth. Catal. 2013,
355, 1495.
Supporting Information
Additional supporting information may be found in the online
version of this article at the publishers web-site.
wileyonlinelibrary.com/journal/aoc
767